NAFLD is primarily associated with metabolic risk factors, such as obesity, type 2 diabetes, high cholesterol, and metabolic syndrome
16 It is widely expressed in metabolically active tissues, including the liver, heart, skeletal muscle, and adipose tissue, 2325 and is involved in diverse cellular processes such as metabolic homeostasis, antioxidant defense, autophagy, inflammation, and energy balance
La respuesta individual vara segn el tipo y dosis del medicamento, caractersticas del paciente (peso inicial, duracin de diabetes, funcin renal), adherencia y estilo de vida
Clinical trials show average weight loss of four to eight pounds monthly during the second and third months of treatment
So I think its older thought processes and older perspectives to see weight as like an issue of willpower